- Home
- AMR vs JANX Comparison
AMR vs JANX Comparison
Compare AMR & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMR
- JANX
- Stock Information
- Founded
- AMR 2016
- JANX 2017
- Country
- AMR United States
- JANX United States
- Employees
- AMR N/A
- JANX N/A
- Industry
- AMR Coal Mining
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- AMR Energy
- JANX Health Care
- Exchange
- AMR Nasdaq
- JANX Nasdaq
- Market Cap
- AMR 1.5B
- JANX 1.6B
- IPO Year
- AMR N/A
- JANX 2021
- Fundamental
- Price
- AMR $113.41
- JANX $25.56
- Analyst Decision
- AMR Buy
- JANX Strong Buy
- Analyst Count
- AMR 2
- JANX 7
- Target Price
- AMR $183.00
- JANX $94.29
- AVG Volume (30 Days)
- AMR 282.8K
- JANX 929.3K
- Earning Date
- AMR 05-09-2025
- JANX 05-08-2025
- Dividend Yield
- AMR N/A
- JANX N/A
- EPS Growth
- AMR N/A
- JANX N/A
- EPS
- AMR 2.04
- JANX N/A
- Revenue
- AMR $2,625,170,000.00
- JANX $9,336,000.00
- Revenue This Year
- AMR N/A
- JANX N/A
- Revenue Next Year
- AMR $10.13
- JANX $250.58
- P/E Ratio
- AMR $55.58
- JANX N/A
- Revenue Growth
- AMR N/A
- JANX 28.12
- 52 Week Low
- AMR $100.00
- JANX $22.52
- 52 Week High
- AMR $334.72
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- AMR 37.24
- JANX 37.10
- Support Level
- AMR $123.06
- JANX $24.13
- Resistance Level
- AMR $130.33
- JANX $33.97
- Average True Range (ATR)
- AMR 5.52
- JANX 2.01
- MACD
- AMR 0.10
- JANX -0.61
- Stochastic Oscillator
- AMR 8.85
- JANX 14.53
About AMR Alpha Metallurgical Resources Inc.
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.